A simple intervention — testing pregnant patients for common sexually transmitted infections and treating those found — was associated with a substantially lower risk of preterm birth in a randomised clinical trial. Screening and treating for three common STIs twice during pregnancy corresponded to a 23 percent lower risk of preterm birth compared with standard care, according to researchers at the University of Pennsylvania and the University of Southern California.
Why Infections Threaten Early Labour
Preterm birth — delivery before 37 weeks — is the leading cause of newborn complications and infant mortality worldwide. Infections are a long-suspected contributor: they can trigger inflammation that weakens foetal membranes and prompts early contractions, and several common STIs frequently produce no symptoms, meaning they go undetected and untreated through pregnancy.
That silent quality is exactly what makes screening attractive. A test catches what neither the patient nor a symptom-based examination can, and the infections in question are treatable with established antibiotics. The trial, published in Clinical Infectious Diseases, tested whether systematic screening converts that theory into healthier babies, and its results feature in this week’s public health research coverage.
Reading the Result Carefully
A 23 percent relative reduction is clinically meaningful at population scale, given how many pregnancies STIs touch and how serious preterm birth can be. The trial design — randomised, with a standard-care comparison — gives the finding more weight than observational studies, which can be confounded by the fact that people who seek screening often differ in other ways too.
Questions remain about implementation: which infections to include, how often to test, and how screening performs across different healthcare systems and risk groups. Cost-effectiveness will decide whether guidelines change. But the direction of travel in maternal health research — echoed by the recent push behind women’s health research — is toward earlier, more systematic prevention rather than late intervention.
Preterm Birth Prevention and the Shift in Prenatal Care
The study lands amid renewed attention to what prenatal care screens for and why. Many standard panels were designed decades ago, and researchers increasingly argue they should be revisited with modern evidence about infection, inflammation and the microbiome.
For expectant parents, the immediate takeaway is modest but real: testing offered in pregnancy is not bureaucratic box-ticking. In this trial at least, it was associated with babies arriving closer to term — and in neonatal medicine, every extra week matters enormously.
Preterm birth has resisted decades of attempts to reduce it, which makes any rigorously demonstrated reduction worth attention. If confirmatory work and cost analyses support it, twice-in-pregnancy STI screening could become one of those unglamorous interventions that quietly improves thousands of beginnings.
